Jeffrey Trocio

1.9k total citations
70 papers, 1.4k citations indexed

About

Jeffrey Trocio is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Internal Medicine. According to data from OpenAlex, Jeffrey Trocio has authored 70 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Cardiology and Cardiovascular Medicine, 19 papers in Economics and Econometrics and 18 papers in Internal Medicine. Recurrent topics in Jeffrey Trocio's work include Atrial Fibrillation Management and Outcomes (44 papers), Health Systems, Economic Evaluations, Quality of Life (19 papers) and Venous Thromboembolism Diagnosis and Management (18 papers). Jeffrey Trocio is often cited by papers focused on Atrial Fibrillation Management and Outcomes (44 papers), Health Systems, Economic Evaluations, Quality of Life (19 papers) and Venous Thromboembolism Diagnosis and Management (18 papers). Jeffrey Trocio collaborates with scholars based in United States, United Kingdom and France. Jeffrey Trocio's co-authors include Linda Brubaker, Joshua S. Benner, Zhanna Jumadilova, Kristina M. Fanning, Jay Lin, Melissa Lingohr-Smith, José Alvir, Mohamed Hussein, Michael B. Nichol and Eric S. Rovner and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Jeffrey Trocio

68 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey Trocio United States	20	614	437	395	384	249	70	1.4k
William A. Blumentals United States	22	97 0.2×	67 0.2×	371 0.9×	129 0.3×	14 0.1×	37	1.3k
J. D. K. North New Zealand	15	63 0.1×	107 0.2×	362 0.9×	111 0.3×	10 0.0×	45	901
J. W. Olivier van Till Netherlands	18	109 0.2×	135 0.3×	269 0.7×	102 0.3×	13 0.1×	34	1.1k
Shankar Kumar United Kingdom	16	171 0.3×	10 0.0×	260 0.7×	13 0.0×	99 0.4×	43	813
Serdar Ural United States	15	122 0.2×	8 0.0×	299 0.8×	49 0.1×	74 0.3×	73	1.1k
R. González Spain	12	328 0.5×	2 0.0×	85 0.2×	36 0.1×	338 1.4×	23	763
Nirmanmoh Bhatia United States	14	281 0.5×	16 0.0×	132 0.3×	18 0.0×	14 0.1×	42	603
Mansur Kayataş Türkiye	12	63 0.1×	42 0.1×	111 0.3×	19 0.0×	3 0.0×	54	502
Valery Walker United States	16	25 0.0×	14 0.0×	346 0.9×	374 1.0×	9 0.0×	40	1.1k
José M. Arizón Spain	25	566 0.9×	3 0.0×	403 1.0×	33 0.1×	30 0.1×	126	1.9k

Countries citing papers authored by Jeffrey Trocio

Since Specialization

Citations

This map shows the geographic impact of Jeffrey Trocio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Trocio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Trocio more than expected).

Fields of papers citing papers by Jeffrey Trocio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Trocio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Trocio. The network helps show where Jeffrey Trocio may publish in the future.

Co-authorship network of co-authors of Jeffrey Trocio

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Trocio. A scholar is included among the top collaborators of Jeffrey Trocio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Trocio. Jeffrey Trocio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gupta, Kiran, Jeffrey Trocio, Allison Keshishian, et al.. (2019). Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population. BMC Cardiovascular Disorders. 19(1). 142–142. 18 indexed citations

Deitelzweig, Steven, Xuemei Luo, Kiran Gupta, et al.. (2017). REAL WORLD EVALUATION OF MAJOR BLEEDING RISK AND COSTS FOR ALL CAUSES AND BLEEDING-RELATED HEALTH SERVICES AMONG ELDERLY PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION TREATED WITH APIXABAN OR WARFARIN. Journal of the American College of Cardiology. 69(11). 312–312. 1 indexed citations

Deitelzweig, Steve, Xuemei Luo, Kiran Gupta, et al.. (2016). Abstract 17298: Real-world Evaluation of Healthcare Resource Use and Costs of Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Apixaban vs. Warfarin in the US. Circulation. 134. 1 indexed citations

Trocio, Jeffrey, Amanda Bruno, Prianka Singh, et al.. (2015). Treatment and Discharge Patterns Among Patients Hospitalized With Nonvalvular Atrial Fibrillation (NVAF) Who Transition From the Inpatient to Outpatient Setting. CHEST Journal. 148(4). 66A–66A.

Deitelzweig, Steven, et al.. (2015). Early assessment of bleeding-related hospital readmissions among nonvalvular atrial fibrillation patients treated with the new oral anticoagulants using an electronic medical record database in the US. European Heart Journal. 36. 1083–1083. 1 indexed citations

Amin, Alpesh, Amanda Bruno, Jeffrey Trocio, Jay Lin, & Melissa Lingohr-Smith. (2015). Incremental Health Care Burden of Bleeding Among Patients with Venous Thromboembolism in the United States. Journal of Managed Care & Specialty Pharmacy. 21(10). 965–972. 10 indexed citations

Deitelzweig, Steven, Michael A. Evans, Eric Hillson, et al.. (2015). DOES WARFARIN TIME-IN-THERAPEUTIC RANGE AFFECT HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG NONVALVULAR ATRIAL FIBRILLATION PATIENTS IN THE U.S.?. Journal of the American College of Cardiology. 65(10). A1515–A1515. 1 indexed citations

Sussman, Matthew, Jeffrey Trocio, Sebastián Mirkin, et al.. (2015). Prevalence of menopausal symptoms among mid-life women: findings from electronic medical records. BMC Women s Health. 15(1). 58–58. 55 indexed citations

Turakhia, Mintu P., Jason Shafrin, Katalin Bognar, et al.. (2015). ECONOMIC BURDEN OF UNDIAGNOSED NONVALVULAR ATRIAL FIBRILLATION IN THE UNITED STATES. Journal of the American College of Cardiology. 65(10). A475–A475. 1 indexed citations

10.

Turakhia, Mintu P., Jason Shafrin, Katalin Bognar, et al.. (2015). Economic Burden of Undiagnosed Nonvalvular Atrial Fibrillation in the United States. The American Journal of Cardiology. 116(5). 733–739. 61 indexed citations

11.

Farr, Amanda M., Yonghua Jing, Stephen S. Johnston, et al.. (2015). Comparison of hospital length of stay between hospitalized non-valvular atrial fibrillation patients treated with either apixaban or warfarin. Hospital Practice. 43(3). 172–179. 13 indexed citations

12.

Amin, Alpesh, Yonghua Jing, Jeffrey Trocio, et al.. (2014). Evaluation of medical costs associated with use of new oral anticoagulants compared with standard therapy among venous thromboembolism patients. Journal of Medical Economics. 17(11). 763–770. 16 indexed citations

13.

Brubaker, Linda, Elisabeth Piault, C. J. Evans, et al.. (2013). Validation study of the Self-Assessment Goal Achievement (SAGA) questionnaire for lower urinary tract symptoms. International Journal of Clinical Practice. 67(4). 342–350. 15 indexed citations

14.

Piault, Elisabeth, et al.. (2012). Linguistic validation of translation of the self-assessment goal achievement (saga) questionnaire from English. Health and Quality of Life Outcomes. 10(1). 40–40. 15 indexed citations

15.

Lee, Richard K., et al.. (2012). Estimating the quality-of-life impact and cost-effectiveness of alpha-blocker and anti-muscarinic combination treatment in men with lower urinary tract symptoms related to benign prostatic hyperplasia and overactive bladder. Journal of Medical Economics. 15(3). 586–600. 7 indexed citations

16.

Arlandis, Salvador, et al.. (2011). Cost-effectiveness analysis of antimuscarinics in the treatment of patients with overactive bladder in Spain: A decision-tree model. BMC Urology. 11(1). 9–9. 29 indexed citations

17.

Brubaker, Linda, Kristina M. Fanning, Joshua S. Benner, et al.. (2009). Predictors of discontinuing overactive bladder medications. British Journal of Urology. 105(9). 1283–1290. 36 indexed citations

18.

Cristillo, Anthony D., Julianna Lisziewicz, Leilei He, et al.. (2007). HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3. Virology. 366(1). 197–211. 27 indexed citations

19.

Lori, Franco, Jeffrey Trocio, Nyasha Bakare, Libby A. Kelly, & Julianna Lisziewicz. (2005). DermaVir, a novel HIV immunisation technology. Vaccine. 23(17-18). 2030–2034. 27 indexed citations

20.

Lisziewicz, Julianna, Jeffrey Trocio, Lucia Whitman, et al.. (2005). DermaVir: A Novel Topical Vaccine for HIV/AIDS. Journal of Investigative Dermatology. 124(1). 160–169. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact